Nephro-Urology Monthly
Can use the NMP22 BladderChek Decrease the Frequency of Cystoscopy in the Follow up of Patients with Bladder Carcinoma ?
Abstract
Copyright
© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Currently Available Urine-Based Tumour Markers in the Detection of New and Recurrent Urothelial Bladder Cancer
Horstmann M. Currently Available Urine-Based Tumour Markers in the Detection of New and Recurrent Urothelial Bladder Cancer. Nephro-Urol Mon. 2011;4(1):. doi: https://doi.org/10.5812/kowsar.22517006.1841
Prognostic Factors for Intravesical Recurrence in NMIBC: Evaluating the Role of Pyuria, Bacteriuria, and Comorbidities
Ohadian Moghadam S, Menbary Oskouie I, Amini E, Momeni SA, Haddad M, et al. Prognostic Factors for Intravesical Recurrence in NMIBC: Evaluating the Role of Pyuria, Bacteriuria, and Comorbidities. Int J Cancer Manag. 2025;18(1):e151782. doi: https://doi.org/10.5812/ijcm-151782
A Comparison of the Progression and Recurrence Risk Index in Non-Muscle-Invasive Bladder Tumors Detected by Narrow-Band Imaging Versus White Light Cystoscopy, Based on the EORTC Scoring System
Shadpour P, Emami M, Haghdani S. A Comparison of the Progression and Recurrence Risk Index in Non-Muscle-Invasive Bladder Tumors Detected by Narrow-Band Imaging Versus White Light Cystoscopy, Based on the EORTC Scoring System. Nephro-Urol Mon. 2016;8(1):e33240. doi: https://doi.org/10.5812/numonthly.33240
Comparison of Re-TUR Results in Primary Patients with Non-muscle-Invasive Bladder Cancer (NMIBC) of Low, Intermediate, and High-risk for Recurrence Based on the EORTC Scoring System
Khaleghi Mehr F, Shadpour P, Shahrokh H, Narimani N, Abolhasani M, et al. Comparison of Re-TUR Results in Primary Patients with Non-muscle-Invasive Bladder Cancer (NMIBC) of Low, Intermediate, and High-risk for Recurrence Based on the EORTC Scoring System. Nephro-Urol Mon. 2021;13(2):e99800. doi: https://doi.org/10.5812/numonthly.99800
Circulating Levels of M30 and M65 Molecules in Transitional Cell Carcinoma of the Bladder and Their Relation to Tumor Progression
Malek-Hosseini Z, Khezri A, Amirghofran Z. Circulating Levels of M30 and M65 Molecules in Transitional Cell Carcinoma of the Bladder and Their Relation to Tumor Progression. Int J Cancer Manag. 2016;9(2):e4086. doi: https://doi.org/10.17795/ijcp-4086
- Scopus by DOI: 0
Last Update: 19 hours ago
- Scopus by Title: 0
Last Update: 19 hours ago
- Scopus by Title (Ref): 0
Last Update: 17 years ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):